Portal de Periódicos da CAPES

Inferferon and Condylomata Acuminata

1990; Wiley; Volume: 29; Issue: 10 Linguagem: Inglês

10.1111/j.1365-4362.1990.tb03771.x

1365-4632

Mark Lebwohl, Paul Contard,

Autoimmune Bullous Skin Diseases

International Journal of DermatologyVolume 29, Issue 10 p. 699-705 Inferferon and Condylomata Acuminata Mark Lebwohl M.D., Corresponding Author Mark Lebwohl M.D. Department of Dermatology, Mount Sinai School of Medicine, New York, New YorkAddress correspondence to: Mark Lebwohl, M.D., Department of Dermatology, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029.Search for more papers by this authorPaul Contard M.D., Paul Contard M.D. Department of Dermatology, Mount Sinai School of Medicine, New York, New YorkSearch for more papers by this author Mark Lebwohl M.D., Corresponding Author Mark Lebwohl M.D. Department of Dermatology, Mount Sinai School of Medicine, New York, New YorkAddress correspondence to: Mark Lebwohl, M.D., Department of Dermatology, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029.Search for more papers by this authorPaul Contard M.D., Paul Contard M.D. Department of Dermatology, Mount Sinai School of Medicine, New York, New YorkSearch for more papers by this author First published: December 1990 https://doi.org/10.1111/j.1365-4362.1990.tb03771.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Barrasso R, De Brux J, Croissant O, et al. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med. 1987; 15: 916–922. 2 Krebs HB, Schneider V. Human papillomavirus-associated lesions of the penis: Colposcopy, cytology, and histology. Obstet Gynecol. 1987; 70: 299–304. 3 Jenkins HML, Riley VC. A review of outpatient management of female genital warts. Br J Clin Pract. 1980; 31: 273. 4 Barnett TL, Silban JD, McGinley JP. Genital warts: A venereal disease. JAMA. 1954; 154: 333. 5 Powell LC Jr. Condyloma acuminatum. Clin Obstet Gynecol. 1972; 15: 948. 6 Lynch PJ. Condylomata acuminata (anogenital warts). Clin Obstet Gynecol. 1985; 28: 142–151. 7 Condyloma acuminatum. MMWR. 1986; 33: 81. 8 Meanwell CA, Bleckledge G, Cox MF. HPV 16 DNA in normal and malignant cervical epithelium: Implications for the etiology and behavior of cervical neoplasia. Lancet. 1987; 1: 703–708. 9 Grussendorf-Conen E, de Villiers E, Gissman L. Human papillomavirus genomes in penile smears of healthy men. Lancet. 1986; 2: 1092. 10 Lorincz AT, Temple GF, Patterson JA, et al. Correlation of cellular and human papillomavirus DNA in exfoliated cells of the uterine cervix. Obstet Gynecol. 1986; 68: 508–512. 11 Burk RD, Radish AS, Calderin S, et al. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol. 1986; 154: 982–989. 12 Rando RF, Lindheim S, Hasty L, et al. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 1989; 161: 50–55. 13 Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 1987; 40: 198–201. 14 Gary R, Jones R. Relationship between cervical condylomata, pregnancy and subclinical papillomavirus infection. J Reprod Med. 1985; 30: 393–399. 15 Howley PM. On human papillomaviruses. N Engl J Med. 1986; 315: 1089–1090. 16 Kremsdorf D, Favre M, Jablonska S, et al. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol. 1984; 52: 1013–1018. 17 Orth G, Favre M, Breitburd F, et al. Epidermodysplasia verruciformis: A model for the role of papillomavirus in human cancer. In: M Essex, G Todaro, H Hansen, eds. Proceedings of the Cold Spring Harbor Conference on Cell Proliferation. Cold Spring , NY :Cold Spring Harbor Laboratory, 1980; 259–282. 18 Ostrow RS, Bender M, Niimura M, et al. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinoma from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA. 1982; 79: 1634–1638. 19 Pfister H, Gassenmaier A, Nurnberger F, et al. Human papillomavirus 5–DNA in carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. Cancer Res. 1983; 43: 1436–1441. 20 Zur Hausen H. Papillomaviruses in human cancer. Cancer. 1987; 59: 1692–1696. 21 Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis: Presence of human papillomavirus (HPV) structural antigens and of HPV 16–related DNA sequences. Arch Dermatol. 1985; 121: 858–863. 22 Crum CP, Mitao M, Levine RU, et al. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985; 54: 675–681. 23 Reid R, Greenberg M, Jenson AB, et al. Sexually transmitted papillomaviral infections. Am J Obstet Gynecol. 1987; 156: 212–222. 24 Gissmann L, Schwarz E. Persistence and Expression of Human Papillomavirus DNA in Genital Cancer: Papillomaviruses. Chichester :John Wiley and Sons, 1986; 1052–1058. 25 Smotkin D, Berek JS, Fu YS, et al. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol. 1986; 68: 241–244. 26 Beaudenon S, Kremsdorf D, Croissant O, et al. A novel type of human papillomavirus associated with genital neoplasias. Nature. 1986; 321: 246–249. 27 McCance DJ. Human papillomaviruses and cancer. Biochim Biophys Acta. 1986; 823: 195–205. 28 Byrne JC, Tsao MS, Fraser RS, et al. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med. 1987; 317: 873–878. 29 Scully C, Path MRC, Prime S, et al. Papillomaviruses: Their possible role in oral disease. Oral Surg. 1985; 60: 166–174. 30 Naghashfar Z, Sawada E, Kutcher MJ, et al. Identification of genital tract papillomaviruses HPV-6 and HPV-16 in warts of the oral cavity. J Med Virol. 1985; 17: 313–324. 31 Respler DS, Jahn A, Pater A, et al. Isolation and characterization of papillomavirus DNA from nasal inverting (Schneiderian) papillomas. Ann Otol Rhinol Laryngol. 1987; 96: 170–173. 32 Winkler B, Capo V, Reumann W, et al. Human papillomavirus infection of the esophagus: A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique. Cancer. 1985; 55: 149–155. 33 Syrjanen KJ. Histological changes identical to those of condylomatous lesions found in oesophageal squamous cell carcinomas. Arch Geschwulstforsch. 1982; 4: 283–292. 34 Butler TW, Gefter J, Kleto D, et al. Squamous-cell carcinoma of the anus in condylomata acuminatum. Dis Colon Rectum. 1987; 30: 293–295. 35 Bennett RS, Powell KR. Human papillomaviruses: Associations between laryngeal papillomas and genital warts. Pediatr Infect Dis J. 1987; 6: 229–232. 36 Zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1981; 78: 1030. 37 Berman B, Frankfort HM. The human interferon system. Int J Dermatol. 1982; 2: 12–18. 38 Kirby P. Interferon and genital warts: Much potential, modest progress. JAMA. 1988; 259: 570–572. 39 Ringenberg QS, Anderson PC. Interferons in the treatment of skin disease. Int J Dermatol. 1986; 25: 273–279. 40 Week PK, Brandsma JL, Whisnant JK. Interferons in the treatment of human papillomavirus diseases. Cancer Metastasis Rev. 1986; 5: 139–165. 41 Douglas JM, Rogers M, Judson FN. The effect of asymptomatic infection with HTIV-III on the response of anogenital warts to intralesional treatment with recombinant alpha-2 interferon. J Infect Dis. 1986; 154: 331–334. 42 Boot JM, Blog B, Stolz E. Intralesional interferon alfa-2a treatment of condyloma acuminata previously resistant to podo-phyllin resin application. Genitourin Med. 1989; 65: 50–53. 43 Reichman RC, Oakes D, Bonnez W, et al. Treatment of condyloma acuminata with three different interferons administered intralesionally: A double-blind placebo controlled trial. Ann Intern Med. 1988; 108: 675–679. 44 Friedman-Kien AE, Eron LJ, Conant M, et al. Natural interferon alfa for treatment of condyloma acuminata. JAMA. 1988; 259: 533–538. 45 Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condyloma acuminata. N Engl J Med. 1986; 315: 1059–1064. 46 DePalo G, Stefanon B, Rilke F, et al. Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with papillomavirus infection. Int J Tissue React. 1984; 6: 523–527. 47 Geffen JR, Klein RJ, Friedman-Kien AE. Intralesional administration of large doses of human leukocyte interferon for the treatment of condyloma acuminata. J Infect Dis. 1984; 150: 612–615. 48 Reichmann RC, Micha JP, Week PK, et al. Interferon alpha-nl (Wellferon) for refractory genital warts: Efficacy and tolerance of low dose systemic therapy. Antivirol Res. 1988; 10: 41–57. 49 Zachariae H, Larsen PM, Sgaard H. Recombinant interferon alpha-2A (Roferon-A) in a case of Buschke-Lowenstein giant condyloma. Dermatologica. 1988; 177: 175–179. 50 Gross G, Ikenberg H, Roussaki A, et al. Systemic treatment of condyloma acuminata with recombinant interferon alpha-2a: Low dose superior to the high dose regimen. Chemotherapy. 1986; 32: 537–541. 51 Gall SA, Hughes CE, Mounts P, et al. Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata. Obstet Gynecol. 1986; 67: 643–651. 52 Schonfeld A, Nitke S, Schottner A, et al. Intramuscular human interferon beta injections in treatment of condyloma acuminata. Lancet. 1984; 183: 1038–1042. 53 Ikic D, Brnobic A, Jurokovic-Vukelic V, et al. Therapeutic human leucocyte interferon incorporated into ointment and cream on condylomata acuminata. In: D Ikic, ed. Proceedings of a Symposium on Clinical Use of Interferon. Zagreb , Yugoslavia :Yugoslavian Academy of Science and Arts, 1975; 235–244. 54 Vesterinen E, Meyer B, Purola E, et al. Treatment of vaginal condyloma with interferon cream. Lancet. 1984; 1: 187. 55 Keay S, Teng N, Eisenberg M, et al. Topical interferon for treating condyloma acuminata in women. J Infect Dis. 1988; 58: 934–939. 56 Olsen EA, Lichtenstein GR, Wilkinson WE. Changes in serum lipids in patients with condyloma acuminata treated with alfa-nl (Wellferon). J Am Acad Dermatol. 1988; 19: 286–289. 57 Einhorn S, Ling P, Einhorn D, et al. The capacity of blood lymphoid cells to produce alpha and gamma interferon is decreased during alpha interferon therapy. J Clin Lab Immunol. 1987; 23: 35–38. Citing Literature Volume29, Issue10December 1990Pages 699-705 ReferencesRelatedInformation